<?xml version="1.0" encoding="UTF-8"?>
<app-group>
 <app id="app1-molecules-25-03936">
  <title>Supplementary Materials</title>
  <p>The following are available online. Figure S1: 2D and 3D interactions of Benzeneethanamine (A) and Camphenol (B) with the active site of SARS-CoV-2 M
   <sup>pro</sup> (PDB ID: 6W63); Figure S2: 2D and 3D interactions of Strophanthidin (C) and Retinal (D) with the active site of SARS-CoV-2 M
   <sup>pro</sup> (PDB ID: 6W63); Figure S3: 2D and 3D interactions of Trans-geranylgeraniol (E) and 3,4-Dihydroxymandelic acid (F) with the active site of SARS-CoV-2 M
   <sup>pro</sup> (PDB ID: 6W63); Figure S4. 2D and 3D interactions of Imidazolidin-4-one, 2-imino-1-(4-methoxy-6-dimethylamino-1,3,5-triazin-2-yl) (G) and Retinol (F) with the active site of SARS-CoV-2 M
   <sup>pro</sup> (PDB ID: 6W63); Figure S5: 2D and 3D interactions of alpha-Santalol (I) and Santalol, E-cis,epi-.beta- (J) with the active site of SARS-CoV-2 M
   <sup>pro</sup> (PDB ID: 6W63); Figure S6: 2D and 3D interactions of Spiro[4,5]dec-6-en-1-ol, 2,6,10,10-tetramethyl (K) and 3.beta-Hydroxy-5-cholen-24-oic acid (L) with the active site of SARS-CoV-2 M
   <sup>pro</sup> (PDB ID: 6W63); Figure S7: 2D and 3D interactions of Phosphonoacetic acid, 3TMS derivative (M) and Nordazepam, TMS derivative (N) with the active site of SARS-CoV-2 M
   <sup>pro</sup> (PDB ID: 6W63); Figure S8: 2D and 3D interactions of 2,6-Dihydroxybenzoic acid, 3TMS derivative (O) and aR-Turmerone (P) with the active site of SARS-CoV-2 M
   <sup>pro</sup> (PDB ID: 6W63); Figure S9: 2D and 3D interactions of (Z)-.gamma.-Atlantone (Q) and Verbenyl angelate, cis- (R) with the active site of SARS-CoV-2 M
   <sup>pro</sup> (PDB ID: 6W63); Figure S10. 2D and 3D interactions of Tumerone (S) and Dibutyl phthalate (T) with the active site of SARS-CoV-2 M
   <sup>pro</sup> (PDB ID: 6W63); Figure S11: 2D and 3D interactions of (-)-Globulol (U) and Androstan-17-one, 3-ethyl-3-hydroxy-, (5.alpha) (V) with the active site of SARS-CoV-2 M
   <sup>pro</sup> (PDB ID: 6W63); Figure S12: 2D and 3D interactions of Yangambin (W) with the active site of SARS-CoV-2 M
   <sup>pro</sup> (PDB ID: 6W63); Figure S13: 2D and 3D interactions of Nelfinavir (X) and Lopinavir (Y) with the active site of SARS-CoV-2 M
   <sup>pro</sup> (PDB ID: 6W63).
  </p>
 </app>
</app-group>
